Phormed
Atlanta, US · 1 known investors
PhorMed develops next-generation therapies targeting inflammation-driven diseases, particularly rare oncological conditions, using AI-powered targeting technology. The company serves patients with inflammatory and cancer-related diseases, focusing on improving efficacy and safety of first-line treatments.
Founders & leadership
BC
Ben ChangCEO / Director
RM
Ralph MassaPresident of Sales, Marketing and Corporate Development
Board
PR
Professor Richard L. ChangChief Scientific Advisor / Inventor
Investors · 1
Frequently asked questions
- What does Phormed do?
- PhorMed develops next-generation therapies targeting inflammation-driven diseases, particularly rare oncological conditions, using AI-powered targeting technology. The company serves patients with inflammatory and cancer-related diseases, focusing on improving efficacy and safety of first-line treatments.
- Who are Phormed's investors?
- Phormed's investors include Edge Case Capital Partners.
- Where is Phormed headquartered?
- Phormed is headquartered in Atlanta, US.